MDTMedtronic plc

NYSE medtronic.com


$ 81.34 $ 0.27 (0.33 %)    

Friday, 03-May-2024 10:48:54 EDT
QQQ $ 434.92 $ 2.60 (0.6 %)
DIA $ 385.67 $ -1.07 (-0.28 %)
SPY $ 510.10 $ -0.43 (-0.08 %)
TLT $ 89.42 $ -0.69 (-0.77 %)
GLD $ 212.11 $ -1.31 (-0.61 %)
$ 80.92
$ 81.07
$ 81.34 x 200
$ 81.36 x 200
$ 81.07 - $ 81.85
$ 67.71 - $ 89.04
6,338,796
na
107.45B
$ 0.93
$ 25.57
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-27-2024 01-26-2024 10-Q
2 11-30-2023 10-27-2023 10-Q
3 08-31-2023 07-28-2023 10-Q
4 06-22-2023 04-28-2023 10-K
5 03-01-2023 01-27-2023 10-Q
6 12-01-2022 10-28-2022 10-Q
7 09-01-2022 07-29-2022 10-Q
8 06-23-2022 04-29-2022 10-K
9 03-03-2022 01-28-2022 10-Q
10 12-02-2021 10-29-2021 10-Q
11 09-02-2021 07-30-2021 10-Q
12 06-25-2021 04-30-2021 10-K
13 03-05-2021 01-29-2021 10-Q
14 12-03-2020 10-30-2020 10-Q
15 09-03-2020 07-31-2020 10-Q
16 06-19-2020 04-24-2020 10-K
17 02-28-2020 01-24-2020 10-Q
18 12-03-2019 10-25-2019 10-Q
19 08-30-2019 07-26-2019 10-Q
20 06-21-2019 04-26-2019 10-K
21 03-01-2019 01-25-2019 10-Q
22 11-29-2018 10-26-2018 10-Q
23 08-31-2018 07-27-2018 10-Q
24 06-22-2018 04-27-2018 10-K
25 03-02-2018 01-26-2018 10-Q
26 12-04-2017 10-27-2017 10-Q
27 09-01-2017 07-28-2017 10-Q
28 06-27-2017 04-28-2017 10-K
29 03-03-2017 01-27-2017 10-Q
30 12-05-2016 10-28-2016 10-Q
31 09-07-2016 07-29-2016 10-Q
32 06-28-2016 04-29-2016 10-K
33 03-09-2016 01-29-2016 10-Q
34 12-09-2015 10-30-2015 10-Q
35 09-09-2015 07-31-2015 10-Q
36 06-23-2015 04-24-2015 10-K
37 02-27-2015 01-23-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 medtronic-says-it-received-fda-approval-for-inceptiv-closed-loop-spinal-cord-stimulator-for-the-treatment-of-chronic-pain

Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord ...

 medical-device-manufacture-integer-to-gain-from-expanding-pulsed-field-ablation-market-earns-upgrade-from-bofa

BofA Securities' upgrades Integer, highlighting the growth potential of pulsed field ablation (PFA) in atrial fibrillation ...

 jim-cramer-says-wesco-international-is-a-buy-recommends-buying-this-stock-under-20

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Medtronic (NYSE: MDT). "I like what they’re d...

 medtronic-announced-evolut-tavr-platform-met-both-co-primary-endpoints-of-clinical-non-inferiority-and-hemodynamic-superiority-at-one-year

New data from largest head-to-head randomized control TAVR trial demonstrates non-inferior clinical outcomes and superior valve...

 johnson--johnson-strong-strategic-fit-for-shockwave-medical-but-medtronic-boston-scientific-could-be-other-bidder-says-analyst

Johnson & Johnson reportedly in talks to acquire Shockwave Medical. Potential acquisition aligns with J&J's interes...

 medtronics-latest-generation-of-transcatheter-aortic-valve-replacement-implant-passes-fdas-muster-shares-gain

FDA approves Medtronic's Evolut FX+ TAVR system for severe aortic stenosis. Enhanced coronary access, maneuverability for d...

 vizai-and-medtronic-collaborate-to-improve-post-acute-stroke-patient-care-in-the-united-states

Viz.ai, Inc., the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic collabo...

Core News & Articles

Today, the PTAB invalidated 10 of the 15 challenged claims in Medtronic's ‘314 patent and declined to invalidate the challe...

 us-patent-office-rejects-axonics-latest-challenge-to-medtronic-patents-medtronic-will-now-ask-the-federal-court-to-lift-its-stay-on-the-lawsuit-and-proceed-to-trial-on-the-five-valid-and-affirmed-patents

Medtronic moves for patent infringement litigation to resume DUBLIN, March 21, 2024  /CNW/ -- Medtronic (NYSE:MDT), the global...

 wall-streets-most-accurate-analysts-views-on-3-health-care-stocks-delivering-high-dividend-yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

Core News & Articles

New pharmacokinetic data demonstrate Virtue® SAB enables extended release of sirolimus above required tissue concentrations i...

 medtronic-authorizes-5b-for-share-repurchases

In addition to approving the dividend, the board today authorized the expenditure of funds for share repurchases. Given the rem...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION